The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free generic EpiPens to ...

S hares of Amneal Pharmaceuticals AMRX, a commercial-stage company marketing generics as well as specialty pharmaceutical ...

BRIDGEWATER, N.J., September 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") and Shilpa Medicare Limited ("Shilpa") announced U.S ...

A pharmaceutical corporation sued Colorado Friday in federal court aiming to bring a halt to a law approved in 2023, which ...

Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.52 which represents a decrease of $-0.18 or -2.07% from the prior close of $8.7. The stock opened at $8.67 and touched a low ...

Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and ...